APA

Marcom P. K., Isaacs C., Harris L., Wong Z. W., Kommarreddy A., Novielli N., Mann G., Tao Y. & Ellis M. J. (20070719). The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers. : Breast cancer research and treatment.

Chicago

Marcom P Kelly, Isaacs Claudine, Harris Lyndsay, Wong Zee Wang, Kommarreddy Aruna, Novielli Nellie, Mann Gretchen, Tao Yu and Ellis Matthew J. 20070719. The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers. : Breast cancer research and treatment.

Harvard

Marcom P. K., Isaacs C., Harris L., Wong Z. W., Kommarreddy A., Novielli N., Mann G., Tao Y. and Ellis M. J. (20070719). The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers. : Breast cancer research and treatment.

MLA

Marcom P Kelly, Isaacs Claudine, Harris Lyndsay, Wong Zee Wang, Kommarreddy Aruna, Novielli Nellie, Mann Gretchen, Tao Yu and Ellis Matthew J. The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers. : Breast cancer research and treatment. 20070719.